{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:47:05Z","timestamp":1648939625922},"reference-count":6,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.09.003","type":"journal-article","created":{"date-parts":[[2007,9,21]],"date-time":"2007-09-21T07:13:34Z","timestamp":1190358814000},"page":"7717","source":"Crossref","is-referenced-by-count":3,"title":["Economic analysis of HPV-vaccines: Not so simple?"],"prefix":"10.1016","volume":"25","author":[{"given":"Ralph","family":"Crott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2007.09.003_bib1","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1016\/j.vaccine.2007.04.086","article-title":"The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada","volume":"25","author":"Brisson","year":"2007","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2007.09.003_bib2","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.vaccine.2007.04.070","article-title":"Do we fully understand the economic value of vaccines?","volume":"25","author":"Drummond","year":"2007","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2007.09.003_bib3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2165\/00019053-200422180-00002","article-title":"Valuing prevention through economic evaluation [article]","volume":"22","author":"Bos","year":"2004","journal-title":"Pharmacoeconomics"},{"issue":"7514","key":"10.1016\/j.vaccine.2007.09.003_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bmj.331.7514.446","article-title":"Need for differential discounting of costs and health effects in cost effectiveness analyses","volume":"331","author":"Brouwer","year":"2005","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.003_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hec.1168","article-title":"Discounting in economic evaluations: stepping forward towards optimal decision rules","volume":"16","author":"Gravelle","year":"2007","journal-title":"Health Econ"},{"issue":"14","key":"10.1016\/j.vaccine.2007.09.003_bib6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2165\/00019053-200220140-00001","article-title":"Theoretical arguments for the discounting of health consequences: where do we go from here?","volume":"20","author":"Lazaro","year":"2002","journal-title":"Pharmacoeconomics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T19:52:19Z","timestamp":1546545139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07010213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":6,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07010213"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}